Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has disclosed the submission of its Audit Report for FY2025, receiving an ‘Unqualified’ audit opinion from its external auditor.
📊 [Key Disclosure Details & Financial Figures]
- External Auditor: KPMG Samjong Accounting Corp.
- Audit Report Receipt Date: February 25, 2026
- Audit Opinion: Unqualified (Applies to both consolidated and separate financial statements; no going concern uncertainty; no adverse internal accounting control opinion)
- Consolidated Financial Position (FY2025):
- Total Assets: KRW 11,060,741,976,837 (Prior Year: KRW 17,336,296,349,511)
- Total Liabilities: KRW 3,609,631,328,852 (Prior Year: KRW 6,431,620,287,493)
- Total Equity: KRW 7,451,110,647,985 (Prior Year: KRW 10,904,676,062,018)
- Capital Stock: KRW 115,727,377,500 (Prior Year: KRW 177,935,000,000)
- Consolidated Financial Performance (FY2025):
- Revenue: KRW 4,556,971,695,180 (KRW 4.56T / Prior Year: KRW 3,497,145,675,782)
- Operating Profit: KRW 2,069,221,266,630 (KRW 2.07T / Prior Year: KRW 1,321,366,380,588)
- Profit Before Tax: KRW 2,118,631,252,684 (KRW 2.12T / Prior Year: KRW 1,384,868,829,747)
- Net Profit: KRW 1,784,352,060,593 (KRW 1.78T / Prior Year: KRW 1,083,315,885,986)
- Number of Consolidated Subsidiaries: 1 (Prior Year: 14)
- Separate Financial Performance (FY2025):
- Revenue: KRW 4,556,971,695,180
- Operating Profit: KRW 2,068,092,839,427
- Net Profit: KRW 1,586,186,963,312
- Other Matters: Financial statements inside the submitted audit report are subject to change during the general meeting of shareholders approval process.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Potential Financial Statement Changes During Shareholder Meeting Approval
The financial statements in this report are submitted prior to approval at the Annual General Meeting of Shareholders (AGM), and figures may be subject to change during the approval process.
Confirming whether the submitted financial figures are approved without adjustments during the AGM is crucial for determining the final status of the audit report figures.
Relevant final outcomes can be verified in upcoming AGM result disclosures and annual business reports.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
